S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
TSE:LABS

MediPharm Labs (LABS) Stock Price, News & Analysis

C$0.08
0.00 (0.00%)
(As of 04/17/2024 ET)
Today's Range
C$0.08
C$0.08
50-Day Range
C$0.07
C$0.10
52-Week Range
C$0.06
C$0.10
Volume
41,580 shs
Average Volume
232,849 shs
Market Capitalization
C$32.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LABS stock logo

About MediPharm Labs Stock (TSE:LABS)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

LABS Stock Price History

LABS Stock News Headlines

This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
Stocks in play: MediPharm Labs Corp.
Life Science REIT PLC (JL6.SG)
Canadian Markets Might Open Slightly Up
MediPharm Labs Corp LABS
Closing Bell: Medipharm Labs Corp down on Tuesday (LABS)
Closing Bell: Medipharm Labs Corp up on Tuesday (LABS)
See More Headlines
Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
130
Year Founded
N/A

Profitability

Net Income
C$-13,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$33.06 million
Cash Flow
C$0.06 per share
Book Value
C$0.18 per share

Miscellaneous

Free Float
N/A
Market Cap
C$32.10 million
Optionable
Not Optionable
Beta
1.04
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. David A. Pidduck
    CEO & Director
  • Mr. Keith Strachan
    Co-Founder & President
  • Mr. Greg Hunter
    Chief Financial Officer
  • Mr. Patrick McCutcheon
    Founder
  • Mr. Saravan Subramaniam
    Vice President of Operations & Supply Chain
  • Mr. Geoffrey Marr
    Executive VP & General Counsel
  • Mr. Brett Moon
    Vice President of Sales
  • Mr. Kirk Binns
    Executive Vice President of Global Accounts

LABS Stock Analysis - Frequently Asked Questions

How have LABS shares performed in 2024?

MediPharm Labs' stock was trading at C$0.07 at the start of the year. Since then, LABS shares have increased by 23.1% and is now trading at C$0.08.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of MediPharm Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST).

How do I buy shares of MediPharm Labs?

Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:LABS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners